HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 276, Issue 25, 22614-22620, June 22, 2001

This Article Abstract Full Text (PDF) All Versions of this Article: 276/25/22614    most recent M101927200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mehta, D. Articles by Malik, A. B. Search for Related Content PubMed PubMed Citation Articles by Mehta, D. Articles by Malik, A. B. Social Bookmarking                      What's this?

Protein Kinase C- Signals Rho-Guanine Nucleotide Dissociation Inhibitor Phosphorylation and Rho Activation and Regulates the Endothelial Cell Barrier Function^*

Dolly Mehta, Arshad Rahman, and Asrar B. Malik

From the Department of Pharmacology, The University of Illinois College of Medicine, Chicago, Illinois 60612

Received for publication, March 2, 2001, and in revised form, April 2, 2001

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

The Rho-GDP guanine nucleotide dissociation inhibitor (GDI) complexes with the GDP-bound form of Rho and inhibits its activation. We investigated the role of protein kinase C (PKC) isozymes in the mechanism of Rho activation and in signaling the loss of endothelial barrier function. Thrombin and phorbol 12-myristate 13-acetate induced rapid phosphorylation of GDI and the activation of Rho-A in human umbilical venular endothelial cells. Inhibition of PKC by chelerythrine chloride abrogated the thrombin-induced GDI phosphorylation and Rho activation. Depletion of PKC prevented the thrombin-induced GDI phosphorylation and Rho activation, thereby indicating that these events occurred downstream of phorbol ester-sensitive PKC isozyme activation. The depletion of PKC or inhibition of Rho by C3 toxin also prevented the thrombin-induced decrease in transendothelial electrical resistance (a measure of increased transendothelial permeability), thus indicating that PKC-induced barrier dysfunction was mediated through Rho-dependent pathway. Using inhibitors and dominant-negative mutants, we found that Rho activation was regulated by PKC-. Moreover, the stimulation of human umbilical venular endothelial cells with thrombin induced rapid association of PKC- with Rho. Activated PKC- but not PKC- induced marked phosphorylation of GDI in vitro. Taken together, these results indicate that PKC- is critical in regulating GDI phosphorylation, Rho activation, and in signaling Rho-dependent endothelial barrier dysfunction.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

The vascular endothelium consisting of the monolayer of endothelial cells and the extracellular matrix represents the major barrier for the exchange of liquid and solutes across the vessel wall (1-4). Thrombin by binding to the endothelial cell surface protease-activated receptor-1 induces a repertoire of signaling events that result in the development of minute gaps among cells, thereby mediating increased vascular permeability, a hallmark of tissue inflammation (5-7). Loss of endothelial barrier function primarily occurs as a result of cell shape change via actinomyosin driven contraction activated by myosin light chain phosphorylation and actin polymerization (3, 8-11).

Studies have shown an important role of the small GTPase, Rho, in the regulation of cytoskeletal dynamics, actin stress fiber formation, and myosin light chain-phosphorylation, and thus by inference, in the control of endothelial barrier function (11-13). The multiple functions of Rho are mediated through the tightly regulated GTP-binding/GTPase cycle (14-16). Three different classes of proteins are required for this regulation: (i) guanine nucleotide exchange factors (GEFs),¹ which stimulate the GTP-GDP exchange reaction; (ii) GTPase-activating proteins (GAPs), which stimulate the GTP-hydrolytic reaction; and (iii) guanine nucleotide dissociation inhibitors (GDIs), which by binding to Rho block the dissociation of GDP from Rho GTPases (17). Furthermore, GDI is also capable of inhibiting GTP hydrolysis by Rho family GTPases as well as stimulating the release of Rho-GTPases from cellular membranes, thereby shutting off the Rho cycle (18). Thus, GDI plays a critical role in the signaling events regulated by Rho-GTPases (19).

The GDP-bound form of Rho complexed with GDI is not activated by Rho-GEFs, suggesting that Rho activation critically depends upon upstream factors mediating the dissociation of GDI from Rho (19-21). The mechanisms activating the dissociation of Rho-GDI from the Rho-GDP complex remain to be determined. It has been suggested that the dissociation of Rho-GDI might be facilitated by members of ezrin/radixin/moesin family of proteins (22, 23). However, Rho-GDI was found to interact only with the N-terminal fragment of radixin but not the full-length radixin, indicating the need of upstream effectors that are required to induce the unfolding of radixin (23). Furthermore, several studies indicate that the translocation and activation of ezrin/radixin/moesin proteins to the membrane are critically dependent on Rho, thereby indicating the intervention of other molecules that activate dissociation of GDI from Rho (24, 25).

Rho-GDI is a family consisting of Rho-GDI-1, Ly/D4-GDI, and Rho GDI-III. Of these, Rho-GDI is ubiquitously expressed (19, 22). The structure of Rho-GDI-1 indicates that it contains sequences for phosphorylation by serine-threonine kinases, raising the possibility that Rho-GDI is regulated by signaling mechanisms that induce its phosphorylation.

Protein kinase C (PKC) isozymes are serine-threonine kinases that induce phosphorylation of multiple proteins, which in turn regulate intracellular signaling (26). A PKC-dependent pathway is important in the mechanism of thrombin-induced increase in endothelial permeability (3, 27-30). Because of the possibility that PKC may activate Rho by mediating Rho-GDI phosphorylation, we investigated the role of PKC in the mechanism of thrombin-induced Rho activation and in signaling the loss of endothelial barrier function in human umbilical venular endothelial (HUVE) cells. The present findings suggest the existence of a novel pathway by which thrombin can stimulate Rho activation. This pathway involves PKC--mediated phosphorylation of GDI, which may stimulate GDI dissociation, thereby resulting in Rho activation and increased endothelial permeability.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Materials-- Human -thrombin was obtained from Enzyme Research Laboratories (South Bend, IN). HUVE cells and endothelial growth medium (EBM-2) were obtained from Clonetics (San Diego, CA). Phosphate-buffered saline (PBS) and trypsin were obtained from Life Technologies, Inc. Anti-Rho-A, anti-Rho-GDI, and anti-PKC-, -, -, and - polyclonal antibodies were obtained from Santa Cruz Biotechnology (San Diego, CA). Purified GST-Rho-GDI was purchased from Cytoskeleton, Inc. (Denver, CO).

Endothelial Cell Culture-- HUVE cells were cultured in a T-75 flask coated with 0.1% gelatin in EBM-2 medium supplemented with 10% fetal bovine serum. Cells were maintained at 37 °C in a humidified atmosphere of 5% CO₂ and 95% air until they formed a confluent monolayer. Cells from each of the primary flasks were detached with 0.05% trypsin, 0.02% EDTA and resuspended in fresh culture medium and passaged as described below. In all experiments, unless otherwise indicated, a confluent monolayer of HUVE cells was washed twice with serum-free medium and incubated in serum-free medium for 3-4 h before treatment with the drug. In all experiments, cells between passages 4 and 8 were used.

Transendothelial Cell Resistance-- The time course of endothelial cell retraction, a measure of increased endothelial permeability, was measured according to the procedures described previously (31). HUVE cells grown to confluence on a gelatin-coated small gold electrode (4.9 × 10⁴cm²) were pretreated with 500 nM phorbol 12-myristate 13-acetate (PMA) overnight or with 10 µg/ml of C3 transferase for 16 h in EBM-10% fetal bovine serum medium. After serum deprivation, cells were stimulated with thrombin to measure change in electrical resistance of the endothelial monolayer. The small electrode and larger counter electrode were connected to a phase-sensitive lock-in amplifier. A constant current of 1 µA was supplied by a 1-V 4000-Hz alternating current connected serially to a 1-megohm resistor between the small electrode and the larger counter electrode. The voltage between the small and large electrode was monitored by a lock-in amplifier, stored, and processed on a computer. Data are presented as change in resistive (in phase) portion of impedance normalized to its initial value at time zero.

Measurement of Rho Activity-- pGEX-2T containing rhotekin-Rho binding domain was provided by Dr. M. A. Schwartz (Scripps Research Institute, La Jolla, CA). Bacterial-expressed GST-rhotekin-Rho binding domain (RBD) protein was purified from isopropyl-1-thio--D-galactopyranozide (1 mM)-induced DH5 cells previously transformed with the appropriate plasmid as described previously (32). Confluent HUVE cells grown in 100-mm dishes were stimulated for the indicated times with 50 nM thrombin or 100 nM PMA. Cells were then quickly washed with ice-cold Tris-buffered saline and lysed in lysis buffer (50 mM Tris, pH 7.4, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 500 mM NaCl, 10 mM MgCl₂, 10 µg/ml each of aprotinin and leupeptin, and 1 mM phenylmethylsulfonyl fluoride (PMSF)). Cell lysates were clarified by centrifugation at 14,000 × g at 4 °C for 2 min, and equal volumes of cell lysates were incubated with GST-RBD beads (15 µg) at 4 °C for 1 h. The beads were washed 3 times with wash buffer (50 mM Tris, pH 7.4, 1% Triton X-100, 150 mM NaCl, 10 mM MgCl₂, 10 µg/ml each of aprotinin and leupeptin, and 0.1 mM PMSF), and bound Rho was eluted by boiling each sample in Laemmli sample buffer. Eluted samples from beads and total cell lysate were then electrophoresed on 12.5% SDS-polyacrylamide gel electrophoresis gels, transferred to nitrocellulose, blocked with 5% nonfat milk, and analyzed by Western blotting using a polyclonal anti-Rho-A antibody. The amount of RBD-bound Rho was normalized to the total amount of Rho in cell lysates for quantitation of Rho activity in different samples using scanning densitometry.

Phosphorylation of Rho-GDI-- A serum-starved confluent monolayer of HUVE cells was labeled with 300 µCi/ml ³²P for 4 h in phosphate-free medium, after which they were stimulated with 50 nM thrombin or 100 nM PMA at indicated times. Cells were quickly rinsed twice with ice-cold PBS and then lysed for 20 min on ice with 300 µl of radioimmune precipitation buffer (10 mM Tris, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.5% Nonidet P-40, 1% Triton-X, 1 mM sodium orthovanadate, 1 mM PMSF, and 1 µg/ml each of leupeptin, pepstatin A, and aprotinin). After clearing the lysate by centrifuging at 4 °C at 14,000 × g for 10 min, the lysate was incubated with anti-rabbit polyclonal Rho-GDI antibody for 1 h followed by the addition of protein A-agarose beads overnight at 4 °C. The beads were collected by centrifugation, washed 4 times with radioimmune precipitation buffer, electrophoresed on 4-15% gradient SDS-polyacrylamide gels, and transferred to nitrocellulose for visualization of GDI phosphorylation by autoradiography and for Western blotting with Rho-GDI antibody to verify equal protein loading. Specificity of the Rho-GDI antibody was confirmed by using peptide immunogen as a negative control.

Reporter Gene Constructs, Endothelial Cell Transfections, and Luciferase Assay-- Rho has been shown to be required primarily for agonist-induced SRE reporter gene activity (33). Therefore, we determined using the SRE reporter gene activity, the role of PKC isozymes in the mechanism of Rho activation. The pSRE-luciferase plasmid was kindly provided by Dr. T. Kozasa (University of Illinois, Chicago, IL). C3 transferase, produced by Clostridium botulinum that specifically ADP-ribosylates and inhibits Rho protein (34), was purified from an Escherichia coli pGEX-2r-bcr recombinant vector expression system as described previously (35).

The expression vector pcDNA3-containing tagged dominant-negative form of PKC- and PKC- isozymes were provided by Dr. I. B. Weinstein (Columbia University, New York, NY). The dominant-negative PKC-, PKC-, and PKC- mutants lacking a functional catalytic domain were generated by a substitution of lysine 368, 437, or 376 for arginine, respectively (36). Transfections were performed with DEAE-dextran method (37). 5 µg of DNA were mixed with 50 µg/ml DEAE-dextran in serum-free EBM medium, and the mixture was added onto 70-80% confluent cells. pTKRLUC plasmid (0.125 µg) (Promega Corp., Madison, WI) containing Renilla luciferase gene driven by the constitutively active thymidine kinase promoter was added to normalize the transfection efficiencies. After 1 h, cells were incubated for 4 min with 10% dimethyl sulfoxide (Me₂SO) in serum-free medium, washed twice with EBM-containing 10% fetal bovine serum, and grown to confluence. Cell extracts were prepared and assayed for luciferase activity using the Dual Luciferase Reporter Assay System (Promega, Madison, WI). SRE-luciferase activity was expressed as the ratio of firefly and Renilla luciferase activity. Cell viability (>95%) after transfection was confirmed using trypan blue (Sigma) exclusion assay.

Immunocomplex Protein Kinase Assay-- Phosphorylation of Rho-GDI in vitro was performed using immunocomplexes of PKC- or PKC- obtained after immunoprecipitation of cell lysate with respective PKC antibodies as described previously (38). Confluent cells grown in 100-mm dishes were stimulated for 1 min with 50 nM thrombin, washed quickly with ice-cold PBS, and lysed in radioimmune precipitation buffer containing 50 mM Tris, pH 7.4, 150 mM NaCl, 0.25 mM EDTA, pH 8.0, 1% deoxycholic acid, 1% Triton-X, 5 mM NaF, 1 mM sodium orthovanadate, 1 mM PMSF, and 5 µg/ml each of leupeptin and aprotinin, and 1 µg/ml pepstatin A. The lysate was scraped and cleared by centrifugation at 4 °C at 14,000 × g for 10 min. Cell lysate containing an equal amount of protein was then incubated with anti-rabbit polyclonal PKC- or PKC- antibody for 1 h followed by an addition of protein A-agarose beads overnight at 4 °C.

Beads from each sample were collected by centrifugation, washed twice with ice-cold lysate buffer, then washed 3 times with PBS, and once with PKC kinase assay buffer (25 mM Tris, pH 7.4, 5 mM MgCl₂, 0.5 mM EGTA, 1 mM dithiothreitol, and 20 µg of phosphatidylserine/reaction). The purified GST-Rho-GDI fusion proteins (3 µg) were incubated with immunocomplexes of PKC dissolved in kinase assay buffer for 10 min at 30 °C followed by an addition of cold ATP (20 µM) and 10 µCi of [-³²P]ATP, after which the mixture was incubated for an additional 30 min. The reaction was stopped by the addition of Laemmli sample buffer, and each sample was electrophoresed on 10% SDS-polyacrylamide gel electrophoresis, transferred to nitrocellulose membrane, and exposed to x-ray films. The blots were then subjected to Western blotting with anti-PKC- or PKC- antibodies to verify the equal amount of the protein in each reaction.

Statistical Analysis-- Comparisons among experimental groups were made by ANOVA or Kruskal-Wallis one-way analysis of variance using SigmaStat software. Differences in mean values were considered significant at p < 0.05.

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Thrombin and PMA Activate Rho in HUVE Cells-- We used GST-rhotekin fusion protein, which specifically binds to activated Rho, to quantitate Rho activation (32, 39). Thrombin induced a 3-4-fold increase in Rho activity in a time-dependent manner with a maximum response occurring at 1 min followed by a decline at 10 min (Fig. 1, A and B). We also used PMA, a direct activator of PKC, to determine the role of PKC activation in mediating Rho activation. As shown in Fig. 1, C and D, PMA induced a 2-3-fold increase in Rho activity in a time-dependent manner with maximum activation at 10 min.

View larger version (18K): [in this window] [in a new window]   Fig. 1.   Rho activation induced by thrombin and PMA. HUVE cells grown to confluence were serum-starved, after which they were stimulated with thrombin or PMA. Rho activity was assayed at the indicated times. Rho activity is indicated by the amount of RBD-bound Rho (top) normalized to the amount of Rho in whole cell lysates (bottom). A and C, Western blots from a representative experiment showing activation of Rho in response to thrombin or PMA. B and D, data from multiple experiments shown as means ± S.E. -fold increase in Rho activation (n = 3). Rho activation in response to thrombin was quantitated as -fold increase over activity at time 0. *, values different from unstimulated cells (p < 0.05); -T, -thrombin; , absence; +, presence.

Thrombin-induced Rho Activation Is Secondary to PKC Activation-- To investigate whether PKC acts upstream of Rho activation, we used chelerythrine chloride, a specific (but not isozyme-selective) PKC inhibitor belonging to a new class of PKC inhibitors that interfere with the phosphate acceptor site and non-competitively inhibit the ATP binding site (40, 41). Chelerythrine pretreatment of HUVE cells prevented thrombin-induced Rho activation, indicating that PKC is an upstream regulator of Rho activation (Fig. 2).

View larger version (15K): [in this window] [in a new window]   Fig. 2.   Protein kinase C regulates thrombin-induced Rho activation. HUVE cells were serum-starved, after which they were pretreated without or with chelerythrine for 30 min. Rho activity was assayed after a 1-min thrombin challenge of cells. Rho activity is indicated by the amount of RBD-bound Rho (top) normalized to the amount of Rho in whole cell lysates (bottom). Data are representative of three independent experiments. -T, -thrombin; , absence; +, presence.

To determine whether PKC isozymes involved in thrombin-induced Rho activation were phorbol-sensitive, we studied the effects of PKC depletion by PMA on thrombin-induced Rho activation. HUVE cells were pretreated without or with 500 nM PMA overnight, after which they were stimulated with thrombin to measure Rho activation. Fig. 3A shows that overnight pretreatment of HUVE cells with PMA prevented Rho activation in response to thrombin. Western blot analysis of the cell lysate from these samples showed that exposure of HUVE cells to phorbol esters resulted in the depletion of PKC-, PKC-, and PKC- with PKC- and PKC- being most sensitive to phorbol esters, whereas residual levels of PKC- remained detectable. In contrast phorbol ester treatment had no effect on PKC- (Fig. 3B). Thus, these results indicate that thrombin-induced Rho activation in HUVE cells is regulated by phorbol-sensitive PKC isozymes but not by the atypical PKC isozymes.

View larger version (14K): [in this window] [in a new window]   Fig. 3.   Phorbol ester-sensitive PKC isozymes regulate thrombin-induced Rho activation. HUVE cells were treated overnight with PMA to deplete conventional and novel PKC isozymes as described under "Experimental Procedures." Cells were then lysed after a 1-min thrombin challenge to assay Rho activity. A, Rho activity is indicated by the amount of RBD-bound Rho (top) normalized to the amount of Rho in whole cell lysates (bottom). B, Western blot analysis of PKC isozymes in total cell lysate after overnight treatment without or with PMA. Data are representative of three independent experiments. -T, -thrombin; , absence; +, presence.

Using LY379196 and rottlerin, which inhibit PKC- and PKC- isozymes, respectively (42-44), we ruled out the involvement of PKC- or PKC- isoforms in regulating thrombin-induced Rho activation (data not shown). As these data and the results in Fig. 2 pointed to the phorbol ester-sensitive PKC isozymes, such as PKC-, as being responsible for thrombin-induced Rho activation, we studied the specific role of PKC- in the mechanism of thrombin-induced Rho activation.

PKC- Mediates Rho-dependent Thrombin-induced SRE Reporter Activity in HUVE Cells-- Using the SRE reporter gene activity, we determined the role of PKC isozymes in the mechanism of Rho activation. We used the dominant-negative mutant of PKC- to address its role in thrombin-induced Rho activation. The dominant-negative mutants of PKC- and PKC- were also included in these experiments. In addition, we studied the effect of C3 transferase, which inhibits Rho activation (34), on thrombin-induced SRE activation.

HUVE cells were cotransfected with SRE-luciferase reporter gene construct together without or with C3 transferase and assayed for thrombin-induced SRE luciferase activity. Thrombin increased SRE reporter gene activity by 4-fold, whereas it failed to increase SRE activation in HUVE cells that were cotransfected with C3 transferase. These results indicate that thrombin-induced SRE reporter gene activation is mediated by Rho (Fig. 4A).

View larger version (17K): [in this window] [in a new window]   Fig. 4.   C3 transferase and dominant-negative PKC- prevent thrombin-induced Rho-dependent SRE reporter gene activity. A, HUVE cells transfected with SRE-Luc plasmid in the presence or absence of C3 transferase (2 µg) were assessed for SRE-luciferase activity. Cells were stimulated with thrombin for 5 h prior to SRE activity measurement. SRE-Luc activity is expressed as the ratio of firefly and Renilla luciferase activity. Data are mean ± S.E. (n = 3 for each condition). B, HUVE cells were cotransfected with SRE-Luc plasmid without or with dominant-negative mutants of PKC-, PKC-, and PKC-. Cells were stimulated with thrombin for 5 h prior to SRE activity measurement. SRE-Luc activity is expressed as the ratio of firefly and Renilla luciferase activity. Data are mean ± S.E. (n = 3 for each condition). *, values different from unstimulated cells (p < 0.05); -T, -thrombin; Luc, luciferase; , absence; +, presence.

The results of thrombin-induced SRE reporter gene activity in cells cotransfected with SRE-luciferase reporter without or with dominant-negative mutants of PKC-, PKC-, or PKC- are shown in Fig. 4B. Thrombin-induced SRE reporter gene activity was completely prevented in cells transfected with the dominant-negative mutant of PKC-. In contrast, dominant-negative PKC- or PKC- had no significant effect on thrombin-induced SRE activation. Thus, these results, which show that PKC- is critical in stimulating Rho activation, are in accord with the above findings, which were obtained using pharmacological inhibitors.

Thrombin Induces Rapid Association of Rho with PKC--- To determine whether thrombin-induced regulation of Rho by PKC- occurs as a result of their physical interaction, lysates from cells stimulated without or with thrombin (1-min challenge period) were incubated with GST-rhotekin fusion protein to pull down activated Rho, after which they were subjected to Western blotting with anti-Rho, PKC-, or PKC- antibody. Fig. 5 shows that thrombin induced the rapid association of PKC- and Rho, whereas under similar conditions, Rho and PKC- did not associate.

View larger version (9K): [in this window] [in a new window]   Fig. 5.   Thrombin induces rapid association of Rho with PKC-. Cells stimulated without or with thrombin (for 1 min) were lysed, and the cell lysate was incubated with GST-rhotekin fusion protein to pull down activated Rho. Lysates were then electrophoresed, transferred to nitrocellulose, and Western blotted with anti-Rho-A or anti-PKC- antibody. Western blots from a representative experiment shows the association of Rho with PKC-. -T, -thrombin; , absence; +, presence.

Thrombin and PMA Induces Rho-GDI Phosphorylation in HUVE Cells-- The GDP-bound form of Rho complexed with GDI is not activated by Rho-GEFs (19), suggesting that Rho activation critically depends on upstream factors that activate the dissociation of GDI. Since Rho-GDI contains sequence for phosphorylation, we addressed the possibility that the activation of HUVE cells results in the phosphorylation of GDI. Fig. 6 shows the autoradiograph of GDI phosphorylation in ³²P-labeled HUVE cells in response to thrombin or PMA stimulation. Thrombin as well as PMA induced the rapid phosphorylation of GDI that returned to near basal level at 5 min after challenge (Fig. 6).

View larger version (15K): [in this window] [in a new window]   Fig. 6.   Thrombin and PMA induce Rho-GDI phosphorylation in HUVE cells. HUVE cells grown to confluence were serum-starved, after which they were labeled with 32P for 4 h in phosphate-free medium. Cells were then stimulated with thrombin or PMA for the indicated times and lysed, and Rho-GDI was immunoprecipitated as described under "Experimental Procedures." Proteins bound to protein A-agarose beads were eluted from the beads by boiling them, after which they were electrophoresed and transferred to nitrocellulose membrane for analysis of phosphorylation (top) and Rho-GDI content by Western blotting (bottom). Data are representative of three independent experiments. -T, -thrombin; P-GDI, phosphorylated GDI; , absence; +, presence.

Thrombin-induced GDI Phosphorylation Is Secondary to PKC Activation-- Since thrombin-induced Rho activation was blocked by either PKC depletion of cells or by the inhibition of PKC using chelerythrine, we determined the role of PKC in mediating the phosphorylation of GDI in response to thrombin. Fig. 7 shows the role of PKC in mediating thrombin-induced GDI phosphorylation. We found that depletion of PKC by overnight pretreatment with PMA abrogated thrombin-induced phosphorylation of Rho-GDI. Similarly, the inhibition of PKC by chelerythrine pretreatment prevented the phosphorylation of GDI in response to thrombin stimulation of endothelial cells. Thus, these results demonstrate that phorbol-sensitive PKC isozymes are involved in regulating the phosphorylation of GDI in response to thrombin.

View larger version (16K): [in this window] [in a new window]   Fig. 7.   PKC regulates thrombin-induced Rho-GDI phosphorylation. HUVE cells were depleted of phorbol-sensitive PKC isozymes by overnight treatment with 500 nM PMA. Serum-starved cells were then labeled with 32P for 4 h in phosphate-free medium. In parallel, labeled cells were treated with chelerythrine for 30 min. Cells were then stimulated with thrombin for 1 min and lysed, and Rho-GDI was immunoprecipitated as described under "Experimental Procedures." Proteins bound to protein A-agarose beads were eluted from the beads by boiling them, after which they were electrophoresed and transferred to nitrocellulose membrane for analysis of phosphorylation (top) and Rho-GDI content by Western blotting (bottom). Data are representative of three independent experiments. -T, -thrombin; P-GDI, phosphorylated GDI; , absence; +, presence.

PKC- Phosphorylate Rho-GDI-- As Rho activation was regulated by PKC-, we next performed an immunocomplex protein kinase assay to determine whether PKC- can directly phosphorylate GDI in vitro. HUVE cells were stimulated without or with thrombin, and the lysates were immunoprecipitated with anti-PKC- antibody. These immunocomplexes were used for kinase assay using GST-GDI as a substrate. In parallel, control kinase reactions were performed using immunocomplexes obtained from cells immunoprecipitated using anti-PKC- antibody. As shown in Fig. 8, GST-GDI was slightly phosphorylated by PKC- in unstimulated cells, but GDI phosphorylation increased markedly in the kinase reaction in cells treated with thrombin. In contrast, PKC- failed to induce the phosphorylation of GST-GDI in kinase reaction regardless of whether the immunocomplex was obtained from stimulated or unstimulated cells. The amounts of PKC- or PKC- in each reaction were equivalent (Fig. 8). Thus, these results indicate that activated PKC- is directly capable of phosphorylating Rho-GDI in vitro.

View larger version (18K): [in this window] [in a new window]   Fig. 8.   PKC- phosphorylates purified GST-GDI in vitro. HUVE cells were serum-starved, after which they were stimulated with thrombin and lysed to immunoprecipitate PKC- or PKC- as described under "Experimental Procedures." PKC immunocomplex was incubated with GST-GDI in kinase buffer containing [-32P]ATP at 30 °C for 30 min. Reactions were then stopped by boiling the samples in SDS sample buffer, after which they were electrophoresed and transferred on nitrocellulose for analysis of GDI phosphorylation by PKC (top) and PKC content by Western blotting (bottom). -T, -thrombin; P-GDI, phosphorylated GDI; , absence; +, presence.

PKC Depletion or Rho Inhibition Inhibits Thrombin-induced Decrease in Transendothelial Electrical Resistance-- The biochemical events by which PKC activation regulates thrombin-induced barrier dysfunction are incompletely understood (3, 27-30). Because the results of this study directly implicate PKC as the upstream regulator of Rho, we measured changes in transendothelial electrical resistance (the basis of increased paracellular endothelial permeability) in PKC-depleted cells or in cells treated with C3 transferase to block Rho activation. As shown in Fig. 9, thrombin caused a significant decrease in resistance in untreated cells, whereas the decreases in resistance in response to thrombin were significantly reduced in cells, which were depleted of phorbol ester-sensitive PKC isozymes, as well as in cells treated with C3 transferase.

View larger version (25K): [in this window] [in a new window]   Fig. 9.   Effects of inhibition of Rho and depletion of PKC on thrombin-induced endothelial cell retraction. HUVE cells grown to confluence on gold electrodes were either pretreated overnight with 500 nM PMA to deplete phorbol ester-sensitive PKC isozymes (top) or pretreated for 16 h with 10 µg/ml C3 transferase (bottom). Cells were then serum-deprived after, which they were stimulated with 50 nM thrombin to measure the changes in transendothelial electrical resistance in real time. Similar results were obtained in two other experiments. T, -thrombin.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Rho activation plays an important role in the mechanism of increased transendothelial permeability induced by mediators such as thrombin (11-13, 39); however, the mechanisms of activation of Rho, thereby the loss of endothelial barrier integrity, are not elucidated (39). The dissociation of GDI from Rho-GDP complex is a prerequisite for the activation of Rho by Rho-GEF (19, 22, 45, 46). As GDI may play a critical role in mediating thrombin-induced Rho activation and thus in signaling increased endothelial permeability, we addressed in this study the basis of Rho activation and its contribution in mediating the loss of endothelial barrier function induced by thrombin.

The present results provide several lines of evidence that Rho-GDI phosphorylation and Rho activation are regulated by a PKC-dependent pathway in endothelial cells. We showed that thrombin as well as the direct activation of PKC by PMA induced the phosphorylation of Rho-GDI and that the Rho-GDI phosphorylation occurred concurrently with the thrombin-induced activation of Rho. Furthermore, the inhibition of PKC by chelerythrine (a specific but not isozyme-selective inhibitor of PKC) abrogated not only thrombin-induced Rho activation but also Rho-GDI phosphorylation. We also showed that the phosphorylation of GDI and Rho activation is regulated by phorbol ester-sensitive isozymes as the depletion of these isozymes by exposing HUVE cells to phorbol esters in the standard manner prevented thrombin-induced GDI phosphorylation and Rho activation. Because the PKC isozymes, -, -, -, and -, expressed in endothelial cells are all phorbol ester-sensitive, we used both pharmacological and genetic approaches to further identify the specific PKC isozyme regulating GDI phosphorylation and Rho activation.

We found that the treatment of HUVE cells with LY379196 or rottlerin, which inhibits PKC- or PKC- isozymes, respectively, failed to prevent Rho activation in response to thrombin in endothelial cells. Using dominant-negative mutant constructs, we showed that dominant-negative PKC- failed to prevent thrombin-induced SRE reporter gene activity that is regulated by Rho. Furthermore, we found that Rho-mediated SRE reporter gene activity in response to thrombin was completely prevented in endothelial cells transfected with the dominant-negative mutant of PKC-, whereas PKC- had no significant effect on thrombin-induced SRE activation. Thus, these data demonstrate that PKC- is the major kinase regulating Rho activation in endothelial cells. As the above findings indicate the critical role of PKC- activation in the regulation of Rho activation, we used in vitro kinase assay to test the possibility that PKC- can directly phosphorylate GDI. Results of the in vitro kinase assay using PKC- and PKC- immunoprecipitates from unstimulated and stimulated cells indicated that only PKC- from activated cells was capable of inducing phosphorylation of GST-GDI. Thus, these findings indicate that the activation of PKC- is required for phosphorylation of Rho-GDI, although the possibility cannot be ruled out that PKC may also activate another protein kinase controlling the phosphorylation state of GDI in HUVE cells.

We also found in the pull-down assay that stimulation of endothelial cells with thrombin leads to a rapid association of PKC- with the activated Rho, although it failed to associate with PKC-. The association of PKC- with Rho after activation, although not in resting cells, indicates that the protein complex formation is probably important in targeting and regulating Rho function (14, 47). However, our results do not distinguish between the possibility that association of PKC- with Rho can occur directly or whether it is mediated by intermediate factors.

There is little information regarding the role of different PKC isoforms in regulating the activation of Rho. Studies in endothelial and epithelial cells have implicated Rho in PMA-induced recruitment of PKC- to the cell membrane (48); however, these observations were not confirmed in bovine arterial endothelial cells (49). A permissive role of PKC- but not PKC- in sphingosine 1-phosphate-induced Rho-A translocation from cytosol to membrane (an indirect measure of Rho activation) was also recently reported in C2C12 myoblasts (50). Thus, on the basis of using multiple approaches our results provide unequivocal evidence that PKC- is a key upstream regulator of Rho activation.

Several studies have implicated a critical role of PKC-dependent pathway in regulating thrombin-induced increase in endothelial permeability (3, 27-30). We, therefore, measured changes in transendothelial electrical resistance (the basis of increased paracellular endothelial permeability) (31) using cells depleted of PKC by PMA treatment or cells treated with C3 transferase to inhibit Rho. We used these cells to address the possibility that PKC-induced barrier dysfunction can be explained by Rho activation. The results showed that thrombin caused a decrease in transendothelial electrical resistance, whereas depletion of PKC or inhibition of Rho reduced the response. Thus, these observations indicate that PKC induces the permeability increase activated by thrombin via the Rho-mediated pathway.

What are the implications of PKC--induced GDI phosphorylation in the mechanism of Rho activation? It has been shown that the cytoplasmic pool of Rho-GTPase is complexed with GDI proteins (45); thus, GDI can influence both the cellular localization and cycling of Rho proteins between GDP- and GTP-bound states. The dissociation of GDI from the Rho protein is a prerequisite for membrane association and its activation by Rho-GEFs (19, 20). In bovine neutrophils, phosphorylation/dephosphorylation events have been implicated in the regulation of the dissociation of the Rho/Rho-GDI complex (51). Based on our results of thrombin-induced phosphorylation of GDI and Rho activation through a PKC-dependent pathway, we hypothesize that phosphorylation/dephosphorylation of GDI may play a role in the mechanism of PKC--induced activation of Rho. Thus, the results of this study describe a novel pathway of GDI phosphorylation and Rho activation regulated by PKC- and in signaling PKC-induced loss of endothelial barrier function.

	ACKNOWLEDGEMENTS

We thank Dr. Martin Schwartz for providing rhotekin-Rho binding domain construct and Dr. Tohru Kozasa for providing SRE-luciferase construct. We thank Dr. I. B. Weinstein for providing PKC-, PKC-, and PKC- isozyme constructs. We also thank Arash Jalali for expert technical assistance and Mike Holinstat and Dr. K. Anwar for help in purifying SRE construct and luciferase activity measurements.

	FOOTNOTES

^* This work was supported by the Midwest affiliate of the American Heart Association and NHLBI, National Institutes of Health Grants HL27016, HL46350, and HL45638.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Pharmacology, The University of Illinois College of Medicine, 835 S. Wolcott Ave., Chicago, IL 60612. Tel.: 312-355-0236; Fax: 312-996-1225; E-mail: dmehta@uic.edu.

Published, JBC Papers in Press, April 17, 2001, DOI 10.1074/jbc.M101927200

	ABBREVIATIONS

The abbreviations used are: GEF, guanine nucleotide exchange factor; GAP, GTPase-activating protein; GDI, guanine nucleotide dissociation inhibitor; PKC, protein kinase C; HUVE cells, human umbilical venular endothelial cells; EBM, endothelial growth medium; PBS, phosphate-buffered saline; PMA, phorbol 12-myristate 13-acetate; GST, glutathione S-transferase; RBD, rhotekin-Rho binding domain; PMSF, phenylmethylsulfonyl fluoride; SRE, serum response element; ANOVA, analysis of variance.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. P. Johnson, A. F. El-Yazbi, K. Takeya, E. J. Walsh, M. P. Walsh, and W. C. Cole Ca2+ sensitization via phosphorylation of myosin phosphatase targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response J. Physiol., June 1, 2009; 587(11): 2537 - 2553. [Abstract] [Full Text] [PDF]

				M. Y. Xu, J. Porte, A. J. Knox, P. H. Weinreb, T. M. Maher, S. M. Violette, R. J. McAnulty, D. Sheppard, and G. Jenkins Lysophosphatidic Acid Induces {alpha}v{beta}6 Integrin-Mediated TGF-{beta} Activation via the LPA2 Receptor and the Small G Protein G{alpha}q Am. J. Pathol., April 1, 2009; 174(4): 1264 - 1279. [Abstract] [Full Text] [PDF]

				H. Abramovici, P. Mojtabaie, R. J. Parks, X.-P. Zhong, G. A. Koretzky, M. K. Topham, and S. H. Gee Diacylglycerol Kinase {zeta} Regulates Actin Cytoskeleton Reorganization through Dissociation of Rac1 from RhoGDI Mol. Biol. Cell, April 1, 2009; 20(7): 2049 - 2059. [Abstract] [Full Text] [PDF]

				M. Minhajuddin, K. M. Bijli, F. Fazal, A. Sassano, K. I. Nakayama, N. Hay, L. C. Platanias, and A. Rahman Protein Kinase C-{delta} and Phosphatidylinositol 3-Kinase/Akt Activate Mammalian Target of Rapamycin to Modulate NF-{kappa}B Activation and Intercellular Adhesion Molecule-1 (ICAM-1) Expression in Endothelial Cells J. Biol. Chem., February 13, 2009; 284(7): 4052 - 4061. [Abstract] [Full Text] [PDF]

				A. M. Bair, P. B. Thippegowda, M. Freichel, N. Cheng, R. D. Ye, S. M. Vogel, Y. Yu, V. Flockerzi, A. B. Malik, and C. Tiruppathi Ca2+ Entry via TRPC Channels Is Necessary for Thrombin-induced NF-{kappa}B Activation in Endothelial Cells through AMP-activated Protein Kinase and Protein Kinase C{delta} J. Biol. Chem., January 2, 2009; 284(1): 563 - 574. [Abstract] [Full Text] [PDF]

				I. F. Abdullaev, J. M. Bisaillon, M. Potier, J. C. Gonzalez, R. K. Motiani, and M. Trebak Stim1 and Orai1 Mediate CRAC Currents and Store-Operated Calcium Entry Important for Endothelial Cell Proliferation Circ. Res., November 21, 2008; 103(11): 1289 - 1299. [Abstract] [Full Text] [PDF]

				J. Qiao, O. Holian, B.-S. Lee, F. Huang, J. Zhang, and H. Lum Phosphorylation of GTP dissociation inhibitor by PKA negatively regulates RhoA Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1161 - C1168. [Abstract] [Full Text] [PDF]

				J. Gavard and J. S. Gutkind Protein Kinase C-related Kinase and ROCK Are Required for Thrombin-induced Endothelial Cell Permeability Downstream from G{alpha}12/13 and G{alpha}11/q J. Biol. Chem., October 31, 2008; 283(44): 29888 - 29896. [Abstract] [Full Text] [PDF]

				M. Feijoo-Cuaresma, F. Mendez, A. Maqueda, M. A. Esteban, S. Naranjo-Suarez, M. C. Castellanos, M. H. del Cerro, S. N. Vazquez, A. Garcia-Pardo, M. O. Landazuri, et al. Inadequate Activation of the GTPase RhoA Contributes to the Lack of Fibronectin Matrix Assembly in von Hippel-Lindau Protein-defective Renal Cancer Cells J. Biol. Chem., September 5, 2008; 283(36): 24982 - 24990. [Abstract] [Full Text] [PDF]

				R. Ramchandran, D. Mehta, S. M. Vogel, M. K. Mirza, P. Kouklis, and A. B. Malik Critical role of Cdc42 in mediating endothelial barrier protection in vivo Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L363 - L369. [Abstract] [Full Text] [PDF]

				C. Tiedje, I. Sakwa, U. Just, and T. Hofken The Rho GDI Rdi1 Regulates Rho GTPases by Distinct Mechanisms Mol. Biol. Cell, July 1, 2008; 19(7): 2885 - 2896. [Abstract] [Full Text] [PDF]

				W. Koh, R. D. Mahan, and G. E. Davis Cdc42- and Rac1-mediated endothelial lumen formation requires Pak2, Pak4 and Par3, and PKC-dependent signaling J. Cell Sci., April 1, 2008; 121(7): 989 - 1001. [Abstract] [Full Text] [PDF]

				S.-M. Kweon, Y. J. Cho, P. Minoo, J. Groffen, and N. Heisterkamp Activity of the Bcr GTPase-activating Domain Is Regulated through Direct Protein/Protein Interaction with the Rho Guanine Nucleotide Dissociation Inhibitor J. Biol. Chem., February 8, 2008; 283(6): 3023 - 3030. [Abstract] [Full Text] [PDF]

				Y. A. Komarova, D. Mehta, and A. B. Malik Dual Regulation of Endothelial Junctional Permeability Sci. Signal., November 13, 2007; 2007(412): re8 - re8. [Abstract] [Full Text] [PDF]

				N. Knezevic, A. Roy, B. Timblin, M. Konstantoulaki, T. Sharma, A. B. Malik, and D. Mehta GDI-1 Phosphorylation Switch at Serine 96 Induces RhoA Activation and Increased Endothelial Permeability Mol. Cell. Biol., September 15, 2007; 27(18): 6323 - 6333. [Abstract] [Full Text] [PDF]

				G. P. van Nieuw Amerongen and V. W.M. van Hinsbergh Endogenous RhoA Inhibitor Protects Endothelial Barrier Circ. Res., July 6, 2007; 101(1): 7 - 9. [Full Text] [PDF]

				M. Gorovoy, R. Neamu, J. Niu, S. Vogel, D. Predescu, J. Miyoshi, Y. Takai, V. Kini, D. Mehta, A. B. Malik, et al. RhoGDI-1 Modulation of the Activity of Monomeric RhoGTPase RhoA Regulates Endothelial Barrier Function in Mouse Lungs Circ. Res., July 6, 2007; 101(1): 50 - 58. [Abstract] [Full Text] [PDF]

				K. Kuribayashi, K. Nakamura, M. Tanaka, T. Sato, J. Kato, K. Sasaki, R. Takimoto, K. Kogawa, T. Terui, T. Takayama, et al. Essential role of protein kinase C {zeta} in transducing a motility signal induced by superoxide and a chemotactic peptide, fMLP J. Cell Biol., March 26, 2007; 176(7): 1049 - 1060. [Abstract] [Full Text] [PDF]

				I. Singh, N. Knezevic, G. U. Ahmmed, V. Kini, A. B. Malik, and D. Mehta G{alpha}q-TRPC6-mediated Ca2+ Entry Induces RhoA Activation and Resultant Endothelial Cell Shape Change in Response to Thrombin J. Biol. Chem., March 16, 2007; 282(11): 7833 - 7843. [Abstract] [Full Text] [PDF]

				J.-K. Min, Y.-L. Cho, J.-H. Choi, Y. Kim, J. H. Kim, Y. S. Yu, J. Rho, N. Mochizuki, Y.-M. Kim, G. T. Oh, et al. Receptor activator of nuclear factor (NF)-{kappa}B ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice Blood, February 15, 2007; 109(4): 1495 - 1502. [Abstract] [Full Text] [PDF]

				Q. Lu, E. O. Harrington, H. Jackson, N. Morin, C. Shannon, and S. Rounds Transforming growth factor-beta1-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation J Appl Physiol, August 1, 2006; 101(2): 375 - 384. [Abstract] [Full Text] [PDF]

				Y. Ugolev, S. Molshanski-Mor, C. Weinbaum, and E. Pick Liposomes Comprising Anionic but Not Neutral Phospholipids Cause Dissociation of Rac(1 or 2){middle dot}RhoGDI Complexes and Support Amphiphile-independent NADPH Oxidase Activation by Such Complexes J. Biol. Chem., July 14, 2006; 281(28): 19204 - 19219. [Abstract] [Full Text] [PDF]

				A. Dovas, A. Yoneda, and J. R. Couchman PKC{alpha}-dependent activation of RhoA by syndecan-4 during focal adhesion formation J. Cell Sci., July 1, 2006; 119(13): 2837 - 2846. [Abstract] [Full Text] [PDF]

				G. M. Yoon, P. E. Dowd, S. Gilroy, and A. G. McCubbin Calcium-Dependent Protein Kinase Isoforms in Petunia Have Distinct Functions in Pollen Tube Growth, Including Regulating Polarity PLANT CELL, April 1, 2006; 18(4): 867 - 878. [Abstract] [Full Text] [PDF]

				C. Cougoule, S. Hoshino, A. Dart, J. Lim, and E. Caron Dissociation of Recruitment and Activation of the Small G-protein Rac during Fc{gamma} Receptor-mediated Phagocytosis J. Biol. Chem., March 31, 2006; 281(13): 8756 - 8764. [Abstract] [Full Text] [PDF]

				S. M. Stamatovic, O. B. Dimitrijevic, R. F. Keep, and A. V. Andjelkovic Protein Kinase C{alpha}-RhoA Cross-talk in CCL2-induced Alterations in Brain Endothelial Permeability J. Biol. Chem., March 31, 2006; 281(13): 8379 - 8388. [Abstract] [Full Text] [PDF]

				A. A. Birukova, D. Adyshev, B. Gorshkov, G. M. Bokoch, K. G. Birukov, and A. D. Verin GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction Am J Physiol Lung Cell Mol Physiol, March 1, 2006; 290(3): L540 - L548. [Abstract] [Full Text] [PDF]

				Z. Xie, W. Su, Z. Guo, H. Pang, S. R. Post, and M. C. Gong Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells Cardiovasc Res, February 1, 2006; 69(2): 491 - 501. [Abstract] [Full Text] [PDF]

				M. Holinstat, N. Knezevic, M. Broman, A. M. Samarel, A. B. Malik, and D. Mehta Suppression of RhoA Activity by Focal Adhesion Kinase-induced Activation of p190RhoGAP: ROLE IN REGULATION OF ENDOTHELIAL PERMEABILITY J. Biol. Chem., January 27, 2006; 281(4): 2296 - 2305. [Abstract] [Full Text] [PDF]

				D. Mehta and A. B. Malik Signaling Mechanisms Regulating Endothelial Permeability Physiol Rev, January 1, 2006; 86(1): 279 - 367. [Abstract] [Full Text] [PDF]

				E. A. Lidington, R. Steinberg, A. R. Kinderlerer, R. C. Landis, M. Ohba, A. Samarel, D. O. Haskard, and J. C. Mason A role for proteinase-activated receptor 2 and PKC-{epsilon} in thrombin-mediated induction of decay-accelerating factor on human endothelial cells Am J Physiol Cell Physiol, December 1, 2005; 289(6): C1437 - C1447. [Abstract] [Full Text] [PDF]

				D. T. Bolick, A. W. Orr, A. Whetzel, S. Srinivasan, M. E. Hatley, M. A. Schwartz, and C. C. Hedrick 12/15-Lipoxygenase Regulates Intercellular Adhesion Molecule-1 Expression and Monocyte Adhesion to Endothelium Through Activation of RhoA and Nuclear Factor-{kappa}B Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2301 - 2307. [Abstract] [Full Text] [PDF]

				D. Mehta Lysophosphatidylcholine: an enigmatic lysolipid Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L174 - L175. [Full Text] [PDF]

				F. Huang, P. V. Subbaiah, O. Holian, J. Zhang, A. Johnson, N. Gertzberg, and H. Lum Lysophosphatidylcholine increases endothelial permeability: role of PKC{alpha} and RhoA cross talk Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L176 - L185. [Abstract] [Full Text] [PDF]

				B. E. Reese, C. Davidson, M. L. Billingsley, and J. Yun Protein Kinase C{epsilon} Regulates Tumor Necrosis Factor-{alpha}-Induced Stannin Gene Expression J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 61 - 69. [Abstract] [Full Text] [PDF]

				Y. Rikitake and J. K. Liao Rho-Kinase Mediates Hyperglycemia-Induced Plasminogen Activator Inhibitor-1 Expression in Vascular Endothelial Cells Circulation, June 21, 2005; 111(24): 3261 - 3268. [Abstract] [Full Text] [PDF]

				C. Papaharalambus, W. Sajjad, A. Syed, C. Zhang, M. O. Bergo, R. W. Alexander, and M. Ahmad Tumor Necrosis Factor {alpha} Stimulation of Rac1 Activity: ROLE OF ISOPRENYLCYSTEINE CARBOXYLMETHYLTRANSFERASE J. Biol. Chem., May 13, 2005; 280(19): 18790 - 18796. [Abstract] [Full Text] [PDF]

				D. Mehta, M. Konstantoulaki, G. U. Ahmmed, and A. B. Malik Sphingosine 1-Phosphate-induced Mobilization of Intracellular Ca2+ Mediates Rac Activation and Adherens Junction Assembly in Endothelial Cells J. Biol. Chem., April 29, 2005; 280(17): 17320 - 17328. [Abstract] [Full Text] [PDF]

				H. Ohkawara, T. Ishibashi, T. Sakamoto, K. Sugimoto, K. Nagata, K. Yokoyama, N. Sakamoto, M. Kamioka, I. Matsuoka, S. Fukuhara, et al. Thrombin-induced Rapid Geranylgeranylation of RhoA as an Essential Process for RhoA Activation in Endothelial Cells J. Biol. Chem., March 18, 2005; 280(11): 10182 - 10188. [Abstract] [Full Text] [PDF]

				S. Eligini, S. Stella Barbieri, V. Cavalca, M. Camera, M. Brambilla, M. De Franceschi, E. Tremoli, and S. Colli Diversity and similarity in signaling events leading to rapid Cox-2 induction by tumor necrosis factor-{alpha} and phorbol ester in human endothelial cells Cardiovasc Res, February 15, 2005; 65(3): 683 - 693. [Abstract] [Full Text] [PDF]

				E. Dransart, A. Morin, J. Cherfils, and B. Olofsson Uncoupling of Inhibitory and Shuttling Functions of Rho GDP Dissociation Inhibitors J. Biol. Chem., February 11, 2005; 280(6): 4674 - 4683. [Abstract] [Full Text] [PDF]

				J. Fu, A. P. Naren, X. Gao, G. U. Ahmmed, and A. B. Malik Protease-activated Receptor-1 Activation of Endothelial Cells Induces Protein Kinase C{alpha}-dependent Phosphorylation of Syntaxin 4 and Munc18c: ROLE IN SIGNALING P-SELECTIN EXPRESSION J. Biol. Chem., February 4, 2005; 280(5): 3178 - 3184. [Abstract] [Full Text] [PDF]

				D. Mehta, J. Bhattacharya, M. A. Matthay, and A. B. Malik Integrated control of lung fluid balance Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1081 - L1090. [Abstract] [Full Text] [PDF]

				K. N. Anwar, F. Fazal, A. B. Malik, and A. Rahman RhoA/Rho-Associated Kinase Pathway Selectively Regulates Thrombin-Induced Intercellular Adhesion Molecule-1 Expression in Endothelial Cells via Activation of I{kappa}B Kinase {beta} and Phosphorylation of RelA/p65 J. Immunol., December 1, 2004; 173(11): 6965 - 6972. [Abstract] [Full Text] [PDF]

				J. Sun and J. T. Barbieri ExoS Rho GTPase-activating Protein Activity Stimulates Reorganization of the Actin Cytoskeleton through Rho GTPase Guanine Nucleotide Disassociation Inhibitor J. Biol. Chem., October 8, 2004; 279(41): 42936 - 42944. [Abstract] [Full Text] [PDF]

				K. Fujii, G. Zhu, Y. Liu, J. Hallam, L. Chen, J. Herrero, and S. Shaw Kinase peptide specificity: Improved determination and relevance to protein phosphorylation PNAS, September 21, 2004; 101(38): 13744 - 13749. [Abstract] [Full Text] [PDF]

				X. Li, C. N. Hahn, M. Parsons, J. Drew, M. A. Vadas, and J. R. Gamble Role of protein kinase C{zeta} in thrombin-induced endothelial permeability changes: inhibition by angiopoietin-1 Blood, September 15, 2004; 104(6): 1716 - 1724. [Abstract] [Full Text] [PDF]

				D. Mehta p120: the guardian of endothelial junctional integrity Am J Physiol Lung Cell Mol Physiol, June 1, 2004; 286(6): L1140 - L1142. [Full Text] [PDF]

				J. Ahamed and W. Ruf Protease-activated Receptor 2-dependent Phosphorylation of the Tissue Factor Cytoplasmic Domain J. Biol. Chem., May 28, 2004; 279(22): 23038 - 23044. [Abstract] [Full Text] [PDF]

				G. U. Ahmmed, D. Mehta, S. Vogel, M. Holinstat, B. C. Paria, C. Tiruppathi, and A. B. Malik Protein Kinase C{alpha} Phosphorylates the TRPC1 Channel and Regulates Store-operated Ca2+ Entry in Endothelial Cells J. Biol. Chem., May 14, 2004; 279(20): 20941 - 20949. [Abstract] [Full Text] [PDF]

				S. H. Shafer and C. L. Williams Elevated Rac1 Activity Changes the M3 Muscarinic Acetylcholine Receptor-Mediated Inhibition of Proliferation to Induction of Cell Death Mol. Pharmacol., May 1, 2004; 65(5): 1080 - 1091. [Abstract] [Full Text]

				T. Minami, A. Sugiyama, S.-Q. Wu, R. Abid, T. Kodama, and W. C. Aird Thrombin and Phenotypic Modulation of the Endothelium Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 41 - 53. [Abstract] [Full Text] [PDF]

				L. S. Price, M. Langeslag, J. P. t. Klooster, P. L. Hordijk, K. Jalink, and J. G. Collard Calcium Signaling Regulates Translocation and Activation of Rac J. Biol. Chem., October 10, 2003; 278(41): 39413 - 39421. [Abstract] [Full Text] [PDF]

				M. Aepfelbacher, C. Trasak, G. Wilharm, A. Wiedemann, K. Trulzsch, K. Krauss, P. Gierschik, and J. Heesemann Characterization of YopT Effects on Rho GTPases in Yersinia enterocolitica-infected Cells J. Biol. Chem., August 29, 2003; 278(35): 33217 - 33223. [Abstract] [Full Text] [PDF]

				D. Mehta, G. U. Ahmmed, B. C. Paria, M. Holinstat, T. Voyno-Yasenetskaya, C. Tiruppathi, R. D. Minshall, and A. B. Malik RhoA Interaction with Inositol 1,4,5-Trisphosphate Receptor and Transient Receptor Potential Channel-1 Regulates Ca2+ Entry: ROLE IN SIGNALING INCREASED ENDOTHELIAL PERMEABILITY J. Biol. Chem., August 29, 2003; 278(35): 33492 - 33500. [Abstract] [Full Text] [PDF]

				M. Holinstat, D. Mehta, T. Kozasa, R. D. Minshall, and A. B. Malik Protein Kinase C{alpha}-Induced p115RhoGEF Phosphorylation Signals Endothelial Cytoskeletal Rearrangement J. Biol. Chem., August 1, 2003; 278(31): 28793 - 28798. [Abstract] [Full Text] [PDF]

				G. S. Bogatkevich, E. Tourkina, C. S. Abrams, R. A. Harley, R. M. Silver, and A. Ludwicka-Bradley Contractile activity and smooth muscle {alpha}-actin organization in thrombin-induced human lung myofibroblasts Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L334 - L343. [Abstract] [Full Text] [PDF]

				J. Qiao, F. Huang, and H. Lum PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L972 - L980. [Abstract] [Full Text] [PDF]

				K. Arai, Y. Maruyama, M. Nishida, S. Tanabe, S. Takagahara, T. Kozasa, Y. Mori, T. Nagao, and H. Kurose Differential Requirement of Galpha 12, Galpha 13, Galpha q, and Gbeta gamma for Endothelin-1-Induced c-Jun NH2-Terminal Kinase and Extracellular Signal-Regulated Kinase Activation Mol. Pharmacol., March 1, 2003; 63(3): 478 - 488. [Abstract] [Full Text] [PDF]

				A. Siflinger-Birnboim and A. Johnson Protein kinase C modulates pulmonary endothelial permeability: a paradigm for acute lung injury Am J Physiol Lung Cell Mol Physiol, March 1, 2003; 284(3): L435 - L451. [Abstract] [Full Text] [PDF]

				H. Zeng, D. Zhao, and D. Mukhopadhyay KDR Stimulates Endothelial Cell Migration through Heterotrimeric G Protein Gq/11-mediated Activation of a Small GTPase RhoA J. Biol. Chem., November 22, 2002; 277(48): 46791 - 46798. [Abstract] [Full Text] [PDF]

				A. Kawakami, A. Tanaka, K. Nakajima, K. Shimokado, and M. Yoshida Atorvastatin Attenuates Remnant Lipoprotein-Induced Monocyte Adhesion to Vascular Endothelium Under Flow Conditions Circ. Res., August 9, 2002; 91(3): 263 - 271. [Abstract] [Full Text] [PDF]

				M. L. Chen, C. Pothoulakis, and J. T. LaMont Protein Kinase C Signaling Regulates ZO-1 Translocation and Increased Paracellular Flux of T84 Colonocytes Exposed to Clostridium difficile Toxin A J. Biol. Chem., February 1, 2002; 277(6): 4247 - 4254. [Abstract] [Full Text] [PDF]

				D. Mehta Serine/threonine phosphatase 2B regulates protein kinase C-{alpha} activity and endothelial barrier function Am J Physiol Lung Cell Mol Physiol, September 1, 2001; 281(3): L544 - L545. [Full Text] [PDF]

This Article Abstract Full Text (PDF) All Versions of this Article: 276/25/22614    most recent M101927200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mehta, D. Articles by Malik, A. B. Search for Related Content PubMed PubMed Citation Articles by Mehta, D. Articles by Malik, A. B. Social Bookmarking                      What's this?